Robotic Gait denied as not medically necessary by Blue Cross Blue Shield?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for robotic gait are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Robotic Gait
## Why BCBS Denies Robotic Gait Training on Medical-Necessity Grounds
Blue Cross Blue Shield denies robotic-assisted gait training as not medically necessary when the submitted documentation does not establish — to the plan's satisfaction — that the patient's condition and functional deficits specifically require this intervention, and that conventional physical therapy is insufficient to meet the patient's rehabilitative goals. BCBS medical directors reviewing these requests often apply criteria developed for a broad population and may not appreciate the specific clinical profile that makes a given patient an appropriate candidate for robotic gait training.
Medical-necessity denials for robotic gait training are very commonly appealed and frequently reversed when the prescribing rehabilitation team submits detailed, patient-specific clinical documentation.
## Your Appeal Rights
Under ACA Section 2719, medical-necessity denials are adverse benefit determinations subject to internal appeal and independent external review. Under ERISA Section 503, employer-sponsored plans must provide full-and-fair review. File an internal appeal within 180 days of the denial notice. If the internal appeal is denied, request independent external review within four months of the final internal denial. Expedited review is available when the clinical situation is urgent.
## Building a Strong Medical-Necessity Appeal
The appeal must connect the patient's specific functional deficits to the specific clinical capabilities of robotic gait training — and explain why those deficits cannot be adequately addressed by conventional therapy alone.
Documentation to assemble: - Diagnosis confirmation: the underlying neurological or orthopedic condition, its current severity, and relevant functional assessment findings documented in the chart - Prior rehabilitation history: what therapies have been tried, over what period, with what functional outcomes — include dates and progress note references - Current functional status: ambulation ability, weight-bearing status, balance, endurance, and the specific gait deficits that are the treatment target - Prescriber medical-necessity letter from the physiatrist or neurologist explaining: (a) the patient's specific deficits, (b) why robotic gait training is the appropriate next intervention, (c) what functional goals are expected, and (d) why conventional therapy alone is insufficient - Rehabilitation center documentation supporting the treatment plan
## Criteria-Mapping Structure
Obtain BCBS's medical policy for robotic-assisted gait training — this document contains the eligibility criteria their medical director used to deny the request. Review the FDA clearance documentation for the specific device being used, as regulatory status is often a listed criterion.
For each medical-necessity criterion in the BCBS policy: - Policy criterion: [copy the exact requirement verbatim] - Patient record shows: [cite the specific chart note, assessment finding, or prescriber statement that satisfies it, with date]
Do not rely on a generic letter. The appeal narrative should read as a direct, point-by-point rebuttal of the denial, grounded in the patient's own medical record.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied as not medically necessary of 17ohp Compounded
- Blue Cross Blue Shield denied as not medically necessary of AAT Augmentation
- Blue Cross Blue Shield denied as not medically necessary of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied as not medically necessary of Anti Cd 20 Ocrevus